Pipeline — registered trials by phase
BioWick SureLock Clinical Outcomes Study
— · Rotator Cuff Tear · Completed · est. 2021-05-05
Vanguard TKA With KneeAlign 2 and Without KneeAlign 2
— · Osteoarthritis, Knee · Completed · est. 2018-10-03
An Evaluation of Rigid Sternal Fixation in Supporting Bone Healing and Improving Postoperative Recovery
— · Coronary Artery Disease, Angina Pectoris, Cardiac Valve Disease · Completed · est. 2015-06
MDR ExploR Radial Head System PMCF
— · Elbow Injury · Enrolling By Invitation · est. 2026-08-16
Avenir Complete Post-Market Clinical Follow-Up Study
— · Osteoarthritis, Hip, Avascular Necrosis of Hip, Avascular Necrosis of the Femoral Head · Active Not Recruiting · est. 2035-06-01
A Comparison Between Signature Total Knee Arthroplasty (TKA) to Conventional TKA and Computer Assisted TKA
— · Joint Disease · Completed · est. 2014-12
A Clinical Evaluation of Metal Ion Release From Metal-on-Metal Cementless Total Hip Arthroplasty
— · Osteoarthritis, Avascular Necrosis, Traumatic Arthritis · Completed · est. 2014-03
ZNN Bactiguard Retrograde Femoral Nails PMCF Study
— · Femoral Fracture · Recruiting · est. 2027-12
PMCF Study on the Safety, Performance and Clinical Benefits Data of the ComposiTCP
— · Rotator Cuff Repairs · Recruiting · est. 2026-08
PMCF Study on the Safety, Performance and Clinical Benefits Data of the Anatomical Shoulder 2.0 Fracture System
— · Proximal Humerus Fracture, Posttraumatic Arthrosis After Humeral Head Fracture, Posttraumatic Necrosis of the Humeral Head · Recruiting · est. 2034-01-21
Continuum™ Metal Bearing System in Total Hip Arthroplasty
— · Avascular Necrosis, Osteoarthritis, Inflammatory Arthritis · Completed · est. 2022-10-22
Anatomical Shoulder Domelock System Study
— · Avascular Necrosis, Revision Surgery, Conditions Consequent to Earlier Operations · Active Not Recruiting · est. 2032-12-09
PMCF Study on the Safety, Performance and Clinical Benefits Data of the ToggleLoc™ 2.9mm and JuggerLoc™ in the Shoulder
— · Bankart Lesions, SLAP Lesion, Acromioclavicular; Dislocation · Completed · est. 2024-06-30
NexGen TM Tibia Clinical Outcomes Study
— · Osteoarthritis, Rheumatoid Arthritis, Traumatic Arthritis · Completed · est. 2023-03-30
Persona Ti-Nidium Post-Market Clinical Follow-up
— · Knee Pain Chronic, Osteoarthritis, Rheumatoid Arthritis · Active Not Recruiting · est. 2034-05
A Comparison of Two Different Surgical Techniques for Total Hip Resurfacing
— · Arthritis, Avascular Necrosis · Completed · est. 2013-07
JuggerStitch Post Market Clinical Follow-up Study
— · Meniscus Tear, Tibial, Meniscus Lesion · Completed · est. 2026-04-30
Hi-Fatigue G Bone Cement Retrospective Study
— · Total Hip and Knee Arthroplasties · Recruiting · est. 2026-10
Infection Consortium Study#1
— · PJI · Completed · est. 2025-09-04
Zimmer POLAR Persona - TKA (EMEA Study)
— · Severe Knee Pain, Severe Knee Disability, Osteoarthritis · Active Not Recruiting · est. 2026-12
A Study on M2a Magnum Total Hip Arthroplasty
— · Degenerative Joint Disease, Avascular Necrosis · Completed · est. 2017-02-28
Sidus Stem-Free Shoulder IDE Study
— · Osteoarthritis, Posttraumatic Arthrosis, Rheumatoid Arthritis · Completed · est. 2018-05
Persona IQ Cohort Study
— · Osteo Arthritis Knee, Knee Arthritis, Monitoring Orthopedic Devices · Active Not Recruiting · est. 2026-12
Evaluating Bactisure Wound Lavage in Orthopedic Wounds
— · Infection of Total Knee Joint Prosthesis · Completed · est. 2018-12-22
Post Market Clinical Follow-up (PMCF) Study of the A.L.P.S. Proximal Humerus Plating System
— · Osteoarthritis, Rheumatoid Arthritis, Post-Traumatic Arthritis · Active Not Recruiting · est. 2026-12
No registered trials in this stage.
No registered trials in this stage.
No registered trials in this stage.
No approved products listed under this sponsor in Drugs@FDA (partnered or subsidiary products may be listed elsewhere).
Source: ClinicalTrials.gov (trials where Zimmer Biomet is lead sponsor; 73 active or completed) and Drugs@FDA (0 approved products). Registry data can include older or partnered programs; the company's own pipeline page is the official list.
SEC filings — insider trading forms excluded
- 8-K2026-09-08Current report (material event)
- SCHEDULE 13G/A2026-08-13SCHEDULE 13G/A
- SCHEDULE 13G2026-08-12SCHEDULE 13G
- 8-K2026-08-05Current report (material event)
- 10-Q2026-08-05Quarterly report
- 8-K2026-08-05Current report (material event)
- 8-K2026-06-29Current report (material event)
- 8-K2026-05-27Current report (material event)
- SD2026-05-27SD
- SCHEDULE 13G/A2026-05-15SCHEDULE 13G/A
- 8-K2026-05-12Current report (material event)
- 10-Q2026-05-01Quarterly report
- SCHEDULE 13G2026-04-30SCHEDULE 13G
- 8-K2026-04-28Current report (material event)
- 8-K2026-04-28Current report (material event)
- ARS2026-04-01Annual report to holders
- DEFA14A2026-04-01DEFA14A
- DEF 14A2026-04-01Proxy statement
- SCHEDULE 13G/A2026-03-27SCHEDULE 13G/A
- 10-K2026-02-20Annual report
- SCHEDULE 13G2026-02-17SCHEDULE 13G
- 8-K2026-02-10Current report (material event)
- 8-K2026-01-12Current report (material event)
- 10-Q2025-11-05Quarterly report
- 8-K2025-11-05Current report (material event)
- 8-K2025-10-07Current report (material event)
- 8-K2025-09-04Current report (material event)
- SCHEDULE 13G/A2025-08-13SCHEDULE 13G/A
- 10-Q2025-08-07Quarterly report
- 8-K2025-08-07Current report (material event)
- SCHEDULE 13D2025-07-15SCHEDULE 13D
- 8-K2025-07-14Current report (material event)
- 8-K2025-06-30Current report (material event)
- S-82025-06-20Employee stock plan
- 8-K2025-06-03Current report (material event)
- 8-K2025-05-27Current report (material event)
- SD2025-05-23SD
- SCHEDULE 13G/A2025-05-06SCHEDULE 13G/A
- 10-Q2025-05-05Quarterly report
- 8-K2025-05-05Current report (material event)
Source: SEC EDGAR. Forms 3/4/5 and 144 (insider transactions) are intentionally left out.